Thirdly, Fas ligand (Fas-L) on the tumour endothelial barrier causes the elimination of CD8+ T cells rather than regulatory T cells because of the high c-FLIP expression on regulatory T cells [170]. The gene discussed is FASLG; the disease is neoplasm.